CpG DNA modulates interleukin 1β-induced interleukin-8 expression in human bronchial epithelial (16HBE14o-) cells

<p>Abstract</p> <p>Background</p> <p>Recognition of repeat unmethylated CpG motifs from bacterial DNA through Toll-like receptor (TLR-9) has been shown to induce interleukin (IL)-8 expression in immune cells. We sought to investigate the role of CpG oligodeoxynucleotide...

Full description

Bibliographic Details
Main Authors: Wong Hector R, Lierl Kristin M, Hughes Valerie S, Parilla N William, Page Kristen
Format: Article
Language:English
Published: BMC 2006-06-01
Series:Respiratory Research
Online Access:http://respiratory-research.com/content/7/1/84
id doaj-16134c8adba34307b7b0457eeb03e014
record_format Article
spelling doaj-16134c8adba34307b7b0457eeb03e0142020-11-25T01:39:17ZengBMCRespiratory Research1465-99212006-06-01718410.1186/1465-9921-7-84CpG DNA modulates interleukin 1β-induced interleukin-8 expression in human bronchial epithelial (16HBE14o-) cellsWong Hector RLierl Kristin MHughes Valerie SParilla N WilliamPage Kristen<p>Abstract</p> <p>Background</p> <p>Recognition of repeat unmethylated CpG motifs from bacterial DNA through Toll-like receptor (TLR-9) has been shown to induce interleukin (IL)-8 expression in immune cells. We sought to investigate the role of CpG oligodeoxynucleotides (ODN) on a human bronchial epithelial cells.</p> <p>Methods</p> <p>RT-PCR and Western blot analysis were used to determine expression of TLR-9 in human bronchial epithelial cells (16HBE14o-). Cells were treated with CpG ODN in the presence or absence of IL-1β and IL-8 protein was determined using ELISA. In some cases cells were pretreated with chloroquine, an inhibitor of TLR-9 signaling, or SB202190, an inhibitor of the mitogen activated protein kinase p38, prior to treatment with IL-1β and CpG. TLR9 siRNA was used to silence TLR9 prior to treatment with IL-1β and CpG. IκBα and p38 were assessed by Western blot, and EMSA's were performed to determine NF-κB activation. To investigate IL-8 mRNA stability, cells were treated with IL-1β in the absence or presence of CpG for 2 h and actinomycin D was added to induce transcriptional arrest. Cells were harvested at 15 min intervals and Northern blot analysis was performed.</p> <p>Results</p> <p>TLR-9 is expressed in 16HBE14o- cells. CpG synergistically increased IL-1β-induced IL-8 protein abundance, however treatment with CpG alone had no effect. CpC (a control ODN) had no effect on IL-1β-induced IL-8 levels. In addition, CpG synergistically upregulated TNFα-induced IL-8 expression. Silencing TLR9 using siRNA or pretreatment of cells with chloroquine had little effect on IL-1β-induced IL-8 levels, but abolished CpG-induced synergy. CpG ODN had no effect on NF-κB translocation or DNA binding in 16HBE14o- cells. Treatment with CpG increased phosphorylation of p38 and pretreatment with the p38 inhibitor SB202190 attenuated the synergistic increase in IL-8 protein levels. Analysis of the half-life of IL-8 mRNA revealed that IL-8 mRNA had a longer half-life following the co-treatment of CpG and IL-1β compared to treatment with IL-1β alone.</p> <p>Conclusion</p> <p>Together, these data demonstrate that CpG modulates IL-8 synthesis in the presence of a pro-inflammatory mediator utilizing TLR9 and post-transcriptional mechanisms involving the activation of p38 and stabilization of IL-8 mRNA.</p> http://respiratory-research.com/content/7/1/84
collection DOAJ
language English
format Article
sources DOAJ
author Wong Hector R
Lierl Kristin M
Hughes Valerie S
Parilla N William
Page Kristen
spellingShingle Wong Hector R
Lierl Kristin M
Hughes Valerie S
Parilla N William
Page Kristen
CpG DNA modulates interleukin 1β-induced interleukin-8 expression in human bronchial epithelial (16HBE14o-) cells
Respiratory Research
author_facet Wong Hector R
Lierl Kristin M
Hughes Valerie S
Parilla N William
Page Kristen
author_sort Wong Hector R
title CpG DNA modulates interleukin 1β-induced interleukin-8 expression in human bronchial epithelial (16HBE14o-) cells
title_short CpG DNA modulates interleukin 1β-induced interleukin-8 expression in human bronchial epithelial (16HBE14o-) cells
title_full CpG DNA modulates interleukin 1β-induced interleukin-8 expression in human bronchial epithelial (16HBE14o-) cells
title_fullStr CpG DNA modulates interleukin 1β-induced interleukin-8 expression in human bronchial epithelial (16HBE14o-) cells
title_full_unstemmed CpG DNA modulates interleukin 1β-induced interleukin-8 expression in human bronchial epithelial (16HBE14o-) cells
title_sort cpg dna modulates interleukin 1β-induced interleukin-8 expression in human bronchial epithelial (16hbe14o-) cells
publisher BMC
series Respiratory Research
issn 1465-9921
publishDate 2006-06-01
description <p>Abstract</p> <p>Background</p> <p>Recognition of repeat unmethylated CpG motifs from bacterial DNA through Toll-like receptor (TLR-9) has been shown to induce interleukin (IL)-8 expression in immune cells. We sought to investigate the role of CpG oligodeoxynucleotides (ODN) on a human bronchial epithelial cells.</p> <p>Methods</p> <p>RT-PCR and Western blot analysis were used to determine expression of TLR-9 in human bronchial epithelial cells (16HBE14o-). Cells were treated with CpG ODN in the presence or absence of IL-1β and IL-8 protein was determined using ELISA. In some cases cells were pretreated with chloroquine, an inhibitor of TLR-9 signaling, or SB202190, an inhibitor of the mitogen activated protein kinase p38, prior to treatment with IL-1β and CpG. TLR9 siRNA was used to silence TLR9 prior to treatment with IL-1β and CpG. IκBα and p38 were assessed by Western blot, and EMSA's were performed to determine NF-κB activation. To investigate IL-8 mRNA stability, cells were treated with IL-1β in the absence or presence of CpG for 2 h and actinomycin D was added to induce transcriptional arrest. Cells were harvested at 15 min intervals and Northern blot analysis was performed.</p> <p>Results</p> <p>TLR-9 is expressed in 16HBE14o- cells. CpG synergistically increased IL-1β-induced IL-8 protein abundance, however treatment with CpG alone had no effect. CpC (a control ODN) had no effect on IL-1β-induced IL-8 levels. In addition, CpG synergistically upregulated TNFα-induced IL-8 expression. Silencing TLR9 using siRNA or pretreatment of cells with chloroquine had little effect on IL-1β-induced IL-8 levels, but abolished CpG-induced synergy. CpG ODN had no effect on NF-κB translocation or DNA binding in 16HBE14o- cells. Treatment with CpG increased phosphorylation of p38 and pretreatment with the p38 inhibitor SB202190 attenuated the synergistic increase in IL-8 protein levels. Analysis of the half-life of IL-8 mRNA revealed that IL-8 mRNA had a longer half-life following the co-treatment of CpG and IL-1β compared to treatment with IL-1β alone.</p> <p>Conclusion</p> <p>Together, these data demonstrate that CpG modulates IL-8 synthesis in the presence of a pro-inflammatory mediator utilizing TLR9 and post-transcriptional mechanisms involving the activation of p38 and stabilization of IL-8 mRNA.</p>
url http://respiratory-research.com/content/7/1/84
work_keys_str_mv AT wonghectorr cpgdnamodulatesinterleukin1binducedinterleukin8expressioninhumanbronchialepithelial16hbe14ocells
AT lierlkristinm cpgdnamodulatesinterleukin1binducedinterleukin8expressioninhumanbronchialepithelial16hbe14ocells
AT hughesvaleries cpgdnamodulatesinterleukin1binducedinterleukin8expressioninhumanbronchialepithelial16hbe14ocells
AT parillanwilliam cpgdnamodulatesinterleukin1binducedinterleukin8expressioninhumanbronchialepithelial16hbe14ocells
AT pagekristen cpgdnamodulatesinterleukin1binducedinterleukin8expressioninhumanbronchialepithelial16hbe14ocells
_version_ 1725049539050602496